Drug Patents owned by Benuvia

1. Drug name - SYNDROS

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9345771 BENUVIA Oral cannabinoid formulations
Aug, 2028

(5 years from now)

US8222292 BENUVIA Liquid cannabinoid formulations
Aug, 2028

(5 years from now)

US10265293 BENUVIA Oral cannabinoid formulations
Aug, 2028

(5 years from now)

US11253472 BENUVIA Oral cannabinoid formulations
Aug, 2028

(5 years from now)

Drugs and Companies using DRONABINOL ingredient

Treatment: NA

Dosage: SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
5MG/ML SOLUTION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.